INTRODUCTION
Gastric cancer is one of the few malignant neoplasms for which an infectious agent has been recognized as playing adominant role in its etiology (1). Although its incidence has been declining in many countries, it is still the second cause of cancer mortality,accounting for 700,349 deaths worldwide in 2002 (2). Almost two-thirds of the casesoccur in developing countries and 42% in China alone. The geographical distribution of stomach cancerischaracterized by wide international variations; high-risk areas include Eastern Asia (China, Korea, and Japan), Eastern Europe, and Andean areas of Central and South America. Incidence rates arelow in SouthernAsia, North and East Africa, North America, Australia and New Zealand (2).
Approximately 90% of gastric cancers area denocarcinomas (3). Gastricadenocarcinoma subclassifications based on location and histopathological pattern have beenproposed and show etiologic implications. The histopathological classification of Jarvi and Laurens ubdivides adenocarcinomas into intestinal and diffuse types (4, 5). Intestinal-type gastric adenocarcinoma is predominant in older people, while diffusetype affects younger people and has poorer prognosis. Asmall subsetofdiffuse-type gastricadenocarcinomai sh ereditary,c aused by mutations in the Ecadherin gene (6). Epidemiological evidence has indicated that the bacterium Helicobacter pylori (H. pylori) plays a critical role in the development of both intestinal and diffuse types (7, 8) . According to the anatomic subsite, the most important distinction is betweencardia and non-cardia. H. pylori infectionis implicated in the etiopathogenesis of non-cardia gastric cancer, but it seemsn ot to increase the risk of cardia cancer (9). Althought he incidence of distal (non-cardia) gastric cancer has declined in the United States in the last decades, incidence rates of cardia gastric cancer arei ncreasing rapidly,a long with the incidence rates for esophageal adenocarcinoma (10).
As an infectious disease, the appropriate model to examine gastric cancer causation is the classical epidemiologicparadigm in which the outcome is determined by the virulence of the involvedo rganism, modulated by forces related to the host and to the external environment. Table 1summarizes the factors implicated in the process. In this particular case, the interaction of such forces starts decades beforeclinical cancer is diagnosed, usually in early childhood when the bacterial infection is acquired. The evolution of the processisthat of aclassical chronic active infectious disease. Fig. 1 is adiagrammatic representation of the epidemiologic model of possible pathways of H. pylori infection. When H. pylori colonize the stomach, the initial immune response of the gastric mucosa varies considerably according to the virulence of the strain. Low virulence strains induce amild inflammatory process, which is asymptomatic and will not progress to gastric atrophy or adenocarcinoma. On the contrary, high virulence strains, mainly those containing the cag pathogenicity island, have been associated to severegastric diseases: severe non-atrophic chronic gastritis, gastric and duodenal ulcers, multifocal atrophic gastritis, and adenocarcinoma.
The twom ain outcomes of the inflammation brought about by the bacterial infection arer epresented also in Fig.1 .Non-atrophic chronic gastritisis characterized by chronic inflammatoryi nfiltrate in the gastric mucosa with preservation of the gastric glands.These inflammatory changes may vary from mild, which may be asymptomatic,t om arked,a ccompanied by severesymptomatology.The latter pattern is found also in patients with duodenal ulcer. Gland preservationisconsidered the key event in the avoidance of aneoplastic outcome of the infection.
The second type of response to the infection is characterized by multiple foci of loss of the gastric glands,k nown as multifocal atrophic gastritis. The lost glands areoften replaced by epithelial cells with Etiologic factors related to gastric cancerdevelopment.
Bacterial
Host Environment
Geneticvariants: intestinal phenotype, known as intestinal metaplasia. This typeofresponse to the infection may eventually lead to dysplastic changes and neoplastic transformation. This sequence of histopathological events has been previously described (11) . Thus,the infection may or may not start aprecancerous process. The factorsthat modulate the process and may determine the outcome aree xamined in moredetail in the following paragraphs.
THE BACTERIALAGENT
Gastric colonizationb yH .p ylori represents one of the most common infections worldwide. It is estimated that at least one half of the world population is infected. However,the prevalence of the infection varies widely and is largely determined by the socioeconomic status of the population under study: around 74% of the middle-aged adult population in developing countries, and 58% in developed countries (12) .
H. pylori is agram-negative, microaerophilic bacterium, well-equipped with several mechanismst o evade host defenses and assure asuccessful colonization of the gastric mucosa. Through its production of urease, H. pylori neutralizes the intragastric acidic pH, a necessary factor for the establishment of a persistent infection. Typically,t he bacteria aref ound in the gastric cavity,outside the epithelial cells; most of thema re free-living in the gastricm ucus gel, but therei sas ubpopulation in direct contact with the epithelial cell membrane. H. pylori populations are extremely diverse, due to point mutations, substitutions, insertions and/ord eletions in their genomes (13) . Therea re also marked differences in the virulence of the prevalent strains around the world (14) . Twom ain factors determine the bacterial virulence and area ssociatedw ith secreted toxins:C agA and VacA. The cytotoxin-associated gene A( cagA) is a marker of the cag pathogenicity island (cag PAI), a 40-kb region of the H. pylori chromosome comprising 27-31 genes, depending on the clinical strain. The cag PAIi sf ound in about 50 to 60% of H. pylori strains in Western countries (15) and in over 90% of isolates from Japan (16) . cagA-positive bacteria induce a more severe inflammationthan cagA-negativebacteria and have been associated with greater risk forpeptic ulcer disease, as well as preneoplastic and neoplastic lesions (17) . The cag PAIe ncodes at ype IV secretion system, am echanism by which bacterial products (mainly CagA protein) arei njected by as yringe-like structurei nto the host cells. Once inside the epithelial cell, CagA is phosphorylated at tyrosine residues in EPIYAmotifs by Srckinases. The phosphorylated CagA activates eukaryotic phosphatase (SHP-2), leading to dephosphorylation of host cell proteins and to cytoskeletal changes, forming thes o-called "hummingbird" phenotype. The damage induced by CagA depends on the degree of phosphorylation it undergoes once injectedinto the cell cytoplasm. The phosphorylation is determinedbythe type and numberof the so-called EPIYAmotifs of the CagA protein. Most strainsisolated from Southeast Asian patients (East-ern strains) have EPIYAmotifs that lead to moreextensivep hosphorylation than the EPIYAp atterns found in the West (Western strains) (18) .
The vacuolating cytotoxin is encoded by the vacA gene. Unlike the cag PAI, the vacA gene is present in virtually all H. pylori strains. However,o nly about 50% of H. pylori strains secrete VacA, ah ighly immunogenic protein that induces massive vacuolization of epithelialc ells in vitro ( 19) . Some of the activities of VacA include increase in membrane permeability by formation of pores, and induction of apoptosis (20) . In the vacA gene, two polymorphic regions have been found to determine virulence by influencing the secretion of the vacuolating toxin: the signal (s) and middle (m) regions. Each of these regions is expressed as either type 1o rt ype 2. Vacuolating activity is high in s1/m1g enotypes, intermediate in s1/m2, and absent in s2/m2 genotypes (21) . Strains carryingt he s1 allele aremorevirulent than s2 variants, and m1 variants aremorevirulent than m2 variants. It has been observed that vacA s1/m1 genotypes predominate in populations at high gastric cancer risk (14) and area ssociated with gastric carcinoma (22, 23) , while s2 genotypes aremorefrequent in bacteria isolated from populations at low risk.
Other importantv irulence factors area dhesins, whicha llow binding of theb acteria to the gastric epithelial cells. One of them is BabA, an outer membrane protein, encoded by the babA2 (blood-group antigen binding) gene. BabA protein can bind to the blood-group antigen Lewis b present on the surface of the gastric epithelium. It has been observed that H. pylori strains possessing babA2 area ssociated with increased risk for gastric adenocarcinoma (24) .
The ultimate mechanisms by which H. pylorii nduce gastricc ancer remain unknown. Aleading hypothesis implicates oxidative damage in the gastric microenvironment.The presence of activated neutrophils within the inflamed gastric mucosa results in therelease of myeloperoxidase, an enzymethat catalyzes the oxidation of electron donors by hydrogen peroxide. This leads to the generation of reactive oxygen species (ROS) such as superoxide anion radicals, hydrogen peroxide, and subsequently hydroxyl radicals (25) . Under normal conditions, cells areprotected against the toxic effects of high concentrations of ROS by production of protective antioxidante nzymes such as superoxide dismutases (Mn-and Cu,Zn-SOD), catalase, and glutathione peroxidase, among others. An imbalance between the rate of free radical generation and the antioxidant activity leads to oxidative stress. Thus,oxidative damage is caused by theinteraction of ROS with awide variety of macromolecules, such as membranel ipids, cytoplasmic proteins, and nucleic acids (26) .
HOST FACTORS
In the last decade, al arge body of evidence demonstrating the importance of human genetic variants in gastric cancer has been generated (27, 28) . Historically,t he evaluation was based on single nucleotide polymorphisms, assuming independent effects. Con-sidering the complexity of these markersinterms of interactions and linkage disequilibrium, it is necessary to examine the associations among them and gastric cancerrisk using ahaplotype analysis. However,that information is still limited. Identification of marker allelescan be useful for screening, especially in combination with other risk factors.
The host factors that have received moreattention arethoserelatedtothe secretionofthe pro-inflammatory cytokine interleukin 1beta (IL-1b ), avery strong inhibitor of gastric acid secretion. Polymorphisms in IL1B gene have been associated with increased production of IL-1b and elevated gastric cancer risk. Subjects who carry the IL1B-511T polymorphism have a significantly increased risk of gastric cancer in European and North American Caucasian populations (29, 30, 31) . IL1B-31C, in linkage disequilibrium with IL1B-511T,has shown similar results.Several studies in Southeast Asia have failed to find an increased cancer risk associated with the IL1B-511T or IL1B-31C polymorphisms ( 32, 33) . These susceptibility gene polymorphisms arem orep revalent in East Asian populations (51%) than in Caucasians (33%) (34) . When the measureofassociationisthe relative risk, it is mored ifficult to detect an increased risk if the frequencies of the risk-associated alleles areh igh in the general population.
Several other proinflammatory cytokine gene polymorphisms (in IL1B, IL1RN, IL10, IL8, and TNFA genes) have beens tudieds howing inconsistent results (30, 31, 33, 35, 36, 37) . Interestingly,some studies in Asian populations have reported increased gastric cancer risk associated with IL8-251A carriers (33, 38, 39) . This polymorphismhas not been associated with cancer risk in Caucasians (40, 41) .
Interaction among bacterial (cagA and vacA) and host (IL1B, IL1RN) genotypes has revealed that the odds of having gastric carcinoma aret he greatest in subjects with both bacterial and host high-risk genotypes (23, 35) . Simultaneous carriage of several putativehigh-risk alleles has been associated with greater risk for non-cardia gastric cancer,e speciallyi ni ndividuals infected with H. pylori CagA-positive strains (30, 31, 35) .
It has been reported that some polymorphisms in the tumor necrosis factoralpha promoter arefrequent in Amerindianpopulations at high gastric cancer risk (42) . Their potential role as cancer risk markers should be explored.
Ar ecent meta-analysis evaluating the association between methylenetetrahydrofolate reductase (MTH-FR) gene polymorphismsand gastric cancer risk has provided evidence that T/T and C/C genotypes of the MTHFR C677T and A1298C polymorphisms, respectively,contribute to susceptibility of this neoplasia, mainly in East Asians (43) . In aChinese population, the associationb etween ac yclooxygenase-2 (COX-2) gene polymorphism and gastric cancer risk has beenreported (44) . Carriers of thehigh-risk COX-2-1195AA genotype had ahigher expression of COX-2. Ameta-analysis has suggested that the glutathione S-transferase T1 (GSTT1) null genotypeh as av ery small effect on the risk of gastric cancer per se but may modulate thet obacco-related carcinogenesis, and that the combination of unfavorable genotypes may result in an additional gastric cancer risk (45) . Morerecently,acombined analysis of the GSTT1 and glutathioneS -transferase M1 (GSTM1) genetic variants found that those who had null genotypes of GSTM1a nd GSTT1 had an increased gastric cancer risk compared with those who had both active genes (46) .
Finally,the mucins that protect the gastric epithelium from external injuries arep olymorphic: larger moleculess eem to convey morep rotectiona gainst cancer developmentt han smaller molecules. Small MUC1 alleles/genotypes ares ignificantly moref requent in patients with gastric carcinoma (47) .
EXTERNALENVIROMENT
Therei sas tronge nvironmental component to the gastric cancerrisk differences. It has been established that the second generation of migrant populations from high risk areas of the world show am arked decrease in risk when they move to alower risk area. The first generation of migrants maintains the high ratesofthe country of origin (48) .
The infection with H. pylori most frequently occurs in early infancy,f romt he family environment (49) . Factors associated with low socioeconomic status play am ajor role in determining the circumstances leading to H. pylori infection. Residential crowding during infancy is awell-known factor favoring infection, as well as the fact of having infectedo lder siblings (50) . Although the clinical consequences of H. pylori infection in children aren ot well known, the infection has been associated to decreased linear growth (51, 52) and to iron deficiency (53, 54) . It frequently decreases gastric acid secretion and may facilitatethe passage of anaerobic bacteria to the intestine (usually killed by the gastric acid), causing diarrhea (55) .
Aco-morbid condition which may determine the outcome of the infection is intestinal parasitism with helminths. In general, immunologic response to infection is classified as type 1o rt ype 2( Th1 or Th2) according to the predominant pattern of cytokine secretion. The immunologic response to H. pyloriinfection, normally pro-inflammatory Th1, is biased towardaless injurious Th2 response in the presence of helminthic parasites (56) . In the high altitudeColombian Andes(at high gastric cancer risk), the cold climate does not favor the life cycle of helminths and such parasitic infections areless frequent than in the coastal (low risk area for gastric cancer) warm climate regions. The difference in immuner esponse in the two regions is clear,w ith higher levels of immunoglobulin E( an indicator of Th2 response) in the low gastric cancerr isk coastal area (57) . The beneficial effects of parasites in chronic inflammatory bowel disease have been shown in humans: intentional infestation with Trichuris suis improves the clinical course of the disease (58) .
Other external environmentalf actors influencing gastric cancerdevelopment arerelated to diet. Excessive dietarys alt, nitrites and nitrosamine intake in-crease cancer risk (59, 60, 61) . Inadequate intakeo f fresh fruits and vegetables has been universally associated with increased cancer risk (62) . It is not entirelyclear which componentsoffresh fruits and vegetables areresponsible for the protective effect. Antioxidantmicronutrients,highly concentrated in fruits and somev egetables,a re natural candidates.A dequate intake of vitamin Ci sa ssociated with lower gastric cancer risk (63) . Several chemoprevention trials have addressed this issue. As tudy in Colombia showed that after 6years of dietary supplementation with vitamin Cand beta-carotene, partial regression of gastric precancerous lesions was observed (64) . This effect disappeared at 12 years of follow-up, 6 years after the supplements weres uspended. The same trialr eported that curing H. pylorii nfection results in regressionofprecancerous lesions at arate equal to the squareoftime free of infection. Recently, Youe ta lr eported that long-term vitamin (vitamins Cand Eand selenium) or garlic supplementationhad no beneficial effects on prevalence of precancerous gastric lesions or on gastric canceri ncidence, but treating the H. pylori infection retarded the progression of precancerous gastric lesions (65) .
Otherdietary items that may have aprotective effect but need further investigation area llium compounds (garlic and onion) (66, 67) , cruciferous vegetables (broccoli, cabbage, kale and their relatives) (68, 69) , selenium (70) and green tea (71) .
Finally,t obacco smoking has been reported to increase risk of gastricc ancer (72) . Tobacco contains a variety of carcinogens including N-nitroso compounds which have been associated to gastric carcinogenesis (73) .
EPILOGUE
Although gastric cancer incidence hasd ecreased drastically in many countries, it remains am ajor health burden worldwide. Considerable progress has beenmade in clarifying its etiology and pathogenesis. Abacterial infection has been recognizedasthe driving etiologic force. Following classical epidemiologic models, host and environmental factorsmodulate the effects of the bacterial infectiona nd determine its outcome.
Although surgery is thet reatmento fc hoice for gastric cancer, the prognosis of the disease depends on the stage at diagnosis. When the neoplastic cells arel imited to the mucosa and/or submucosa (even in the presence of metastasis to neighboring lymph nodes) surgical or endoscopic resection achievese xcellent prognosis: five-year survival around 95% in Japan for "early"g astric cancer discovered through their early detection and treatmentp rograms (74) . However,t he prognosis is usually dismal once the neoplastic cells have reached the muscularis propria of the gastric wall. In the United States, approximately two thirds of the cases ared iagnosed when the disease has reached localized or distant disseminationand 5-year survival rates are20% and 3%, respectively (75) .
Presently,t he best hope of controlling the disease is through prevention. To detect most tumors at an early stage, cost-effective endoscopic screening programs focusing on individuals at the highest cancer risk areneeded. These individuals could be identified based on the known bacterial and host markers. High virulence markers of H. pylori areCagA positive status, identifiable by serologic tests,a nd VacAs1m1 genotype, presently recognizedbymolecular biology techniques requiring gastric biopsies,t herefore not suitable forn on-invasive screening programs. Identifyingh ost susceptibility markers is as ubject of active scrutiny at the present time. Some IL1B gene polymorphisms areu seful in Caucasians, but not in Asiatic populations. Methylenetetrahydrofolate reductase and IL8 genetic variantsseem to be promising markers in Orientals, but not in Caucasians. Gastric cancer research offers extraordinary opportunities to advance our knowledge of the pathogenesis of neoplastic lesions in general. The fact that the driving force is an identifiable infectious agent which startsad ecades-long chronic inflammation leading to dichotomous( neoplastic versus non-neoplastic) outcome opens broad avenues of research. Encouraging evidence from long-term chemoprevention trials based on H. pylori-therapy has shown that eradication of H. pylori infection is ap romising strategy to control gastric cancer.P revention could be achieved by not allowing the infection to start and maintain a preneoplastic process. The key scientific challenge is to identify theforces which prevent aneoplasticoutcome in tissues subjected to pro-neoplastic stimuli. 
